These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

507 related items for PubMed ID: 19570087

  • 1. Efficacy of glucantime in the treatment of Old World cutaneous leishmaniasis.
    Firdous R, Yasinzai M, Ranja K.
    Int J Dermatol; 2009 Jul; 48(7):758-62. PubMed ID: 19570087
    [Abstract] [Full Text] [Related]

  • 2. Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis.
    Salmanpour R, Handjani F, Nouhpisheh MK.
    J Dermatolog Treat; 2001 Sep; 12(3):159-62. PubMed ID: 12243707
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of azithromycin versus systemic meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis.
    Layegh P, Yazdanpanah MJ, Vosugh EM, Pezeshkpoor F, Shakeri MT, Moghiman T.
    Am J Trop Med Hyg; 2007 Jul; 77(1):99-101. PubMed ID: 17620637
    [Abstract] [Full Text] [Related]

  • 7. Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA, Jaffary F, Moradi S, Derakhshan R, Haftbaradaran E.
    BMC Complement Altern Med; 2007 Apr 27; 7():13. PubMed ID: 17466071
    [Abstract] [Full Text] [Related]

  • 8. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM, Cruz-Saldarriaga M, Llanos-Cuentas A, Luz-Cjuno M, Echevarria J, Miranda-Verastegui C, Colina O, Berman JD.
    Am J Trop Med Hyg; 2005 Feb 27; 72(2):133-7. PubMed ID: 15741547
    [Abstract] [Full Text] [Related]

  • 9. Successful treatment of non-healing cases of cutaneous leishmaniasis, using a combination of meglumine antimoniate plus allopurinol.
    Momeni AZ, Aminjavaheri M.
    Eur J Dermatol; 2003 Feb 27; 13(1):40-3. PubMed ID: 12609780
    [Abstract] [Full Text] [Related]

  • 10. A randomized clinical trial comparing oral azithromycin and meglumine antimoniate for the treatment of American cutaneous leishmaniasis caused by Leishmania (Viannia) braziliensis.
    Krolewiecki AJ, Romero HD, Cajal SP, Abraham D, Mimori T, Matsumoto T, Juarez M, Taranto NJ.
    Am J Trop Med Hyg; 2007 Oct 27; 77(4):640-6. PubMed ID: 17978064
    [Abstract] [Full Text] [Related]

  • 11. Short report: efficacy of pentavalent antimony for treatment of colombian cutaneous leishmaniasis.
    Soto J, Toledo J, Vega J, Berman J.
    Am J Trop Med Hyg; 2005 Apr 27; 72(4):421-2. PubMed ID: 15827279
    [Abstract] [Full Text] [Related]

  • 12. Evaluation of CO laser efficacy in the treatment of cutaneous leishmaniasis.
    Asilian A, Sharif A, Faghihi G, Enshaeieh Sh, Shariati F, Siadat AH.
    Int J Dermatol; 2004 Oct 27; 43(10):736-8. PubMed ID: 15485530
    [Abstract] [Full Text] [Related]

  • 13. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S, Marr JJ.
    N Engl J Med; 1992 Mar 12; 326(11):741-4. PubMed ID: 1738379
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis.
    Armijos RX, Weigel MM, Calvopiña M, Mancheno M, Rodriguez R.
    Acta Trop; 2004 Jul 12; 91(2):153-60. PubMed ID: 15234664
    [Abstract] [Full Text] [Related]

  • 15. Comparison of Thymus vulgaris (Thyme), Achillea millefolium (Yarrow) and propolis hydroalcoholic extracts versus systemic glucantime in the treatment of cutaneous leishmaniasis in balb/c mice.
    Nilforoushzadeh MA, Shirani-Bidabadi L, Zolfaghari-Baghbaderani A, Saberi S, Siadat AH, Mahmoudi M.
    J Vector Borne Dis; 2008 Dec 12; 45(4):301-6. PubMed ID: 19248657
    [Abstract] [Full Text] [Related]

  • 16. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
    Soto J, Rea J, Balderrama M, Toledo J, Soto P, Valda L, Berman JD.
    Am J Trop Med Hyg; 2008 Feb 12; 78(2):210-1. PubMed ID: 18256415
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of intramuscular meglumine antimoniate alone and in combination with intralesional meglumine antimoniate in the treatment of old world cutaneous leishmaniasis.
    Munir A, Janjua SA, Hussain I.
    Acta Dermatovenerol Croat; 2008 Feb 12; 16(2):60-4. PubMed ID: 18541100
    [Abstract] [Full Text] [Related]

  • 18. Both combined oral azithromycin plus allopurinol and intramuscular Glucantime yield low efficacy in the treatment of Old World cutaneous leishmaniasis: a randomized controlled clinical trial.
    Dastgheib L, Naseri M, Mirashe Z.
    Int J Dermatol; 2012 Dec 12; 51(12):1508-11. PubMed ID: 23171020
    [Abstract] [Full Text] [Related]

  • 19. Comparing the efficiency of topical paromomycin with intralesional meglumine antimoniate for cutaneous leishmaniasis.
    Moosavi Z, Nakhli A, Rassaii S.
    Int J Dermatol; 2005 Dec 12; 44(12):1064-5. PubMed ID: 16409282
    [No Abstract] [Full Text] [Related]

  • 20. Current treatment for cutaneous leishmaniasis: a review.
    Palumbo E.
    Am J Ther; 2009 Dec 12; 16(2):178-82. PubMed ID: 19300044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.